2 years ago
BLUE
AnalystsJack AllenJack Allen's Stock Forecasts
AnalystsJack Allen
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#4969 out of 5014 analysts
Average Return
-16.22%
Win Rate
36%14 out of 39
Risk vs Reward
Poor
Good
Jack Allen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Instil Bio IncTIL | +137.60% | $9.02 | $21.42 | 2024-01-16 - 2025-01-16 | Buy |
Instil Bio IncTIL | +119.12% | $9.57 | $20.97 | 2024-01-18 - 2025-01-17 | Buy |
Arcellx IncACLX | +98.19% | $29.30 | $58.07 | 2023-04-13 - 2024-04-12 | Buy |
Mink Therapeutics IncINKT | +90.98% | $7.54 | $14.40 | 2024-11-14 - 2025-09-12 | Buy |
Arcellx IncACLX | +87.26% | $31.01 | $58.07 | 2023-04-13 - 2024-04-12 | Buy |
Jack Allen Analyst Color
Get additional color on Jack Allen's coverage of popular stocks
Jack Allen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vor Biopharma IncVOR | 4 | Hold | $1.00 | -42.53% | Maintains | 3 months ago |
Fate Therapeutics IncFATE | 2 | Hold | $4.00 | +315.37% | Maintains | 4 months ago |
Allogene Therapeutics IncALLO | 3 | Buy | $9.00 | +696.46% | Maintains | 4 months ago |
Carisma Therapeutics IncCARM | 3 | Hold | $1.00 | +167.38% | Downgrades | 9 months ago |
Mink Therapeutics IncINKT | 2 | Buy | $4.00 | -72.22% | Maintains | 10 months ago |
Arcellx IncACLX | 5 | Buy | $106.00 | +39.13% | Maintains | 10 months ago |
Intellia Therapeutics IncNTLA | 2 | Hold | $18.00 | +57.62% | Maintains | a year ago |
Instil Bio IncTIL | 9 | Buy | $180.00 | +646.89% | Reiterates | a year ago |
Bluebird Bio IncBLUE | 3 | Buy | $120.00 | N/A | Maintains | a year ago |
Mereo Biopharma Group PLCMREO | 1 | Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
Crispr Therapeutics AgCRSP | 2 | Hold | $52.00 | N/A | Maintains | a year ago |
Immunocore Holdings PLCIMCR | 1 | Buy | $84.00 | N/A | Initiates Coverage On | 2 years ago |
Korro Bio IncKRRO | 3 | Hold | $0.50 | N/A | Downgrades | 2 years ago |
Taysha Gene Therapies IncTSHA | 4 | Buy | $8.00 | N/A | Maintains | 2 years ago |
Decibel Therapeutics IncDBTX | 2 | Hold | $5.25 | N/A | Downgrades | 2 years ago |
Lineage Cell Therapeutics IncLCTX | 1 | Buy | $5.00 | N/A | Initiates Coverage On | 3 years ago |
Renovacor IncRCOR | 1 | Buy | $9.00 | N/A | Initiates Coverage On | 3 years ago |
Cellectis SaCLLS | 2 | Buy | N/A | N/A | Upgrades | 3 years ago |
Voyager Therapeutics IncVYGR | 1 | Buy | $9.00 | N/A | Upgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.